Seminars in Oncology
Volume 29, Issue 2 , Pages 145-151 , April 2002

Hepatic artery chemoembolization

References 

  1. Raoul JL, Heresbach D, Bretagne JF, et al.  Chemoembolization of hepatocellular carcinomas. Cancer. 1992;70:585–590
  2. Kruskal J, Hlatky L, Hahnfeldt P, et al.  In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors. J Vasc Interv Radiol. 1993;4:741–747
  3. Takayasu K, Wakao F, Moryama N, et al.  Response of early-stage hepatocellular carcinoma and borderline lesions to therapeutic arterial embolization. AJR. 1993;160:301–306
  4. Saitoh S, Ikeda K, Koida I, et al.  Serial hemodynamic measurements in well-differentiated hepatocellular carcinomas. Hepatology. 1995;21:1530–1534
  5. Honda H, Tajima T, Kajiyama K, Kuroiwa T, et al.  Vascular changes in hepatocellular carcinoma: Correlation of radiologic and pathologic findings. AJR. 1999;173:1213–1217
  6. Sadek AG, Mitchell DG, Siegleman ES, et al.  Early hepatocellular carcinoma that develops within macroregenerative nodule: Growth rate depicted at serial MR imaging. Radiology. 1995;195:753–756
  7. Kan Z, Ivancev K, Lunderquist A, et al.  In vivo microscopy of hepatic tumors in animal models: A dynamic investigation of blood supply to hepatic metastases. Radiology. 1993;187:621–626
  8. Kameyama M, Imaoka S, Fukuda I, et al.  Delayed washout of intratumor blood flow is associated with good response to intraarterial chemoembolization for liver metastases of colorectal cancer. Surgery. 1993;114:97–101
  9. Mavligit GM, Pollock RE, Evans HL. Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver. Cancer. 1993;72:375–380
  10. Therasse E, Breittmayer F, Roche A, et al.  Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology. 1993;189:541–547
  11. Stokes KR, Stuart K, Clouse ME. Hepatic arterial chemoembolization for metastatic endocrine tumors. J Vasc Interv Radiol. 1993;4:341–345
  12. Winkelbauer FW, Niederle B, Pietschmann F, et al.  Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: Value of using a mixture of cyanoacrylate and ethiodized oil. AJR. 1995;165:323–327
  13. Carrasco CH, Charnsangavej C, Ajani J, et al.  The carcinoid syndrome: Palliation by hepatic artery embolization. AJR. 1986;147:149–154
  14. Diaco DS, Hajarizadeh H, Mueller CR, et al.  Treatment of metastatic carcinoid tumors using multimodality therapy of ocreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization. Am J Surg. 1995;169:523–528
  15. Drougas JG, Anthony LB, Blair TK, et al.  Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg. 1998;175:408–412
  16. Brown K, Koh BY, Brody LA, et al.  Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol. 1999;10:397–403
  17. Rajan DK, Soulen MC, Clark TW, et al.  Sarcomas metastatic to the liver: Response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization. J Vasc Interv Radiol. 2001;12:187–193
  18. Mavligit GM, Zukwiski AA, Ellis LM, et al.  Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine. Cancer. 1995;75:2083–2088
  19. Mavligit GM, Charnsangavej C, Carrasco H, et al.  Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA. 1988;260:974–976
  20. Sullivan KL, Sato T, Eschelman D, et al.  Survival of patients with hepatic metastases from ocular melanoma following chemoembolization with Ethiodol soluble chemotherapy. J Vasc Interv Radiol. 2001;12:s5–s6 (suppl)
  21. Leichman CG, Jacobson JR, Modiano M, et al.  Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial. Cancer. 1999;86:775–781
  22. Sanz-Altamira PM, Spence LD, Huberman MS, et al.  Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma. A phase II trial. Dis Colon Rect. 1997;40:770–775
  23. Tellez C, Benson AB, Lyster MT, et al.  Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer. 1998;82:1250–1259
  24. Lang EK, Brown CL. Colorectal metastases to the liver: Selective chemoembolization. Radiology. 1993;189:417–422
  25. Bartolozzi C, Lencioni R, Caramella D, et al.  Treatment of large HCC: Transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology. 1995;197:812–818
  26. Yamamoto K, Masuzawa M, Kato M, et al.  Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma. Semin Oncol. 1997;24:S6-50–S6-55 (suppl)
  27. Kim W, Clark TWI, Baum R, et al.  Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol. 2001;12:965–968
  28. Song SY, Chung JW, Han JK, et al.  Liver abscess after transcatheter oily chemoemboization for hepatic tumors: Incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol. 2001;12:313–320
  29. Doppman JL, Girton M, Vermess M. The risk of hepatic artery embolization in the presence of obstructive jaundice. Radiology. 1982;143:37–43
  30. Ito Y, Machen NW, Urbaschek R, et al.  Biliary obstruction exacerbates the hepatic microvascular inflammatory response to endotoxin. Shock. 2000;14:599–604
  31. Caturelli E, Siena DA, Fusilli S. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: Evaluation of damage to nontumorous liver tissue—Long-term prospective study. Radiology. 2000;215:123–128
  32. Leung DA, Goin JE, Sickles C, et al.  Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol. 2001;12:321–326
  33. Fiorentini G, Giovanis P, Leoni M, et al.  Amifostine (Ethyol) as modulator of hepatic and biliary toxicity from intraarterial hepatic chemoembolization: Results of a phase I study. Hepatogastroenterology. 2001;48:313–316
  34. Geschwind JH, Artemov D, Abraham S, et al.  Chemoembolization of liver tumor in a rabbit model: Assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol. 2000;11:1245–1255
  35. Sullivan KL, Aoyama T, Sato T, et al.  Safety of immunoembolization of normal swine liver with human GMCSF (granulocyte macrophage colony stimulating factor) and Ethiodol. J Vasc Interv Radiol. 2001;12:s132–s133 (suppl)

☆ Address reprint requests to Kevin L. Sullivan, MD, Department of Radiology, Division of Cardiovascular and Interventional Radiology, Thomas Jefferson University Hospital, 111 S 11th St, Suite 4200, Philadelphia, PA 19107.

PII: S0093-7754(02)50135-4

doi: 10.1053/sonc.2002.31671

Seminars in Oncology
Volume 29, Issue 2 , Pages 145-151 , April 2002

Article Tools

* Image Usage & Resolution